In the late stage of liver fibrosis in NASH, S100A8, a DAMP considered an inflammatory trigger, can activate the TLR4/NF-κB signaling pathway, leading to upregulation of its target genes NLRP3, IL-1β, and IL-18. The gene discussed is IL18; the disease is metabolic dysfunction-associated steatohepatitis.